Natixis Biogen Inc. Transaction History

Natixis

$16 Billion
Q4 2024

A detailed history of Natixis transactions in Biogen Inc. stock. As of the latest transaction made, Natixis holds 28,392 shares of BIIB stock, worth $3.88 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

28,392

Previous 116,449 75.62%

Holding current value

$3.88 Million

Previous $22.6 Million 80.77%

% of portfolio

0.03%

Previous 0.13%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$146.47 - $191.55 $12.9 Million - $16.9 Million	-88,057 Reduced 75.62%	28,392 $4.34 Million
Q3 2024 Nov 13, 2024	BUY	$189.07 - $236.8 $1.7 Million - $2.12 Million	8,968 Added 8.34%	116,449 $22.6 Million
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $1.09 Million - $1.36 Million	5,743 Added 5.64%	107,481 $24.9 Million
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $7.35 Million - $9.28 Million	34,665 Added 51.68%	101,738 $21.9 Million
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $10.1 Million - $12.2 Million	45,538 Added 211.46%	67,073 $17.4 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $2.63 Million - $2.97 Million	-10,402 Reduced 32.57%	21,535 $5.53 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $4.31 Million - $4.98 Million	15,668 Added 96.31%	31,937 $9.1 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $33.1 Million - $37.7 Million	-128,995 Reduced 88.8%	16,269 $4.52 Million
Q4 2022 Feb 24, 2023	BUY	$252.44 - $306.72 $14.1 Million - $17.1 Million	55,881 Added 62.52%	145,264 $40.2 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $683,607 - $830,597	-2,708 Reduced 2.94%	89,383 $24.8 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $8.66 Million - $11.9 Million	-44,500 Reduced 32.58%	92,091 $24.6 Million
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $8.12 Million - $9.66 Million	43,324 Added 46.45%	136,591 $28 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $23.7 Million - $29.9 Million	-122,407 Reduced 56.76%	93,267 $19.6 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $28.5 Million - $36.6 Million	127,089 Added 143.47%	215,674 $51.7 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $5.3 Million - $6.91 Million	-18,719 Reduced 17.44%	88,585 $25.1 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $16.6 Million - $26.5 Million	63,990 Added 147.74%	107,304 $37.2 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $10.5 Million - $12.3 Million	-43,223 Reduced 49.95%	43,314 $12.1 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $16.4 Million - $24.8 Million	69,604 Added 411.06%	86,537 $21.2 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $4.12 Million - $4.75 Million	-15,542 Reduced 47.86%	16,933 $4.8 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $10.5 Million - $14 Million	-40,786 Reduced 55.67%	32,475 $8.69 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $29.7 Million - $37.6 Million	-110,302 Reduced 60.09%	73,261 $23.2 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $5.23 Million - $7.22 Million	23,753 Added 14.86%	183,563 $54.3 Million
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $3.73 Million - $4.19 Million	17,170 Added 12.04%	159,810 $37.2 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $28.4 Million - $31.3 Million	-129,334 Reduced 47.55%	142,640 $33.4 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $51.3 Million - $80.3 Million	236,794 Added 673.09%	271,974 $63.3 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $17.2 Million - $21.8 Million	-61,881 Reduced 63.75%	35,180 $10.6 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $12.8 Million - $16.8 Million	-43,684 Reduced 31.04%	97,061 $34.3 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $2.49 Million - $2.97 Million	9,687 Added 7.39%	140,745 $40.9 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $8.37 Million - $11.8 Million	32,188 Added 32.56%	131,058 $35.9 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $8.25 Million - $9.24 Million	26,826 Added 37.24%	98,870 $31.5 Million
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $41.9 Million - $49.2 Million	-149,194 Reduced 67.44%	72,044 $22.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	221,238	221,238 $60 Million

Others Institutions Holding BIIB

# of Institutions

995

Shares Held

131M

Call Options Held

1.77M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $19.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account